Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Daiichi Sankyo
Covington
US Army
Teva

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,545,040

« Back to Dashboard

Summary for Patent: 6,545,040
Title: Method of lowering the blood pressure
Abstract:A method of potentiating the effects of blood pressure reducing agents in warm-blooded animals, said method comprising administering to said warm-blooded animals of an effective amount of a blood pressure reducing agent and a 2,2'-iminobisethanol derivative.
Inventor(s): Xhonneux; Raymond Mathieu (Vlimmeren, BE), Van Lommen; Guy Rosalia Eugene (Berlaar, BE)
Assignee: Janssen Pharmaceutica N.V. (BE)
Application Number:07/825,488
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,545,040
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,545,040
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 6,545,040

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Allergan Sales Llc BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-002 Dec 17, 2007 AB RX Yes No ➤ Sign Up ➤ Sign Up Y TREATMENT OF HYPERTENSION ➤ Sign Up
Allergan Sales Llc BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-003 Dec 17, 2007 AB RX Yes No ➤ Sign Up ➤ Sign Up Y TREATMENT OF HYPERTENSION ➤ Sign Up
Allergan Sales Llc BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-004 Dec 17, 2007 AB RX Yes No ➤ Sign Up ➤ Sign Up Y TREATMENT OF HYPERTENSION ➤ Sign Up
Allergan Sales Llc BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-005 Oct 8, 2008 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF HYPERTENSION ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
UBS
Covington
US Department of Justice
Merck
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.